Reported 0 shares, down 450,065 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-03-31 | 8965000 |
| 2022-06-30 | 7386000 |
| 2022-09-30 | 5843000 |
| 2022-12-31 | 14499429 |
| 2023-03-31 | 13392464 |
| 2023-06-30 | 18336569 |
| 2023-09-30 | 68585 |
| 2023-12-31 | 65729 |
| 2024-03-31 | 4743685 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2024 | Reduced | 0 | -450,065 (-100.0%) | 0 | $0 | 2024-08-13 | |
| Q1 2024 | Added | 450,065 | +444,212 (7589.5%) | 0.02% | $4,743,685 | 2024-05-13 | |
| Q4 2023 | Reduced | 5,853 | -19 (-0.3%) | < 0.01% | $65,729 | 2024-02-13 | |
| Q3 2023 | Reduced | 5,872 | -1,813,232 (-99.7%) | < 0.01% | $68,585 | 2023-11-13 | |
| Q2 2023 | Added | 1,819,104 | +4,407 (0.2%) | 0.11% | $18,336,569 | 2023-08-04 | |
| Q1 2023 | Unchanged | 1,814,697 | 0 (0.0%) | 0.09% | $13,392,464 | 2023-05-12 | |
| Q4 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.1% | $14,499,429 | 2023-02-10 | |
| Q3 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.04% | $5,843,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.05% | $7,386,000 | 2022-08-12 | |
| Q1 2022 | New | 1,814,697 | +1,814,697 (0.0%) | 0.05% | $8,965,000 | 2022-05-13 |
Who else reported the position
322 managers reported ROIVANT SCIENCES LTD for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Atalaya Capital Management LP | Added | 1,714,843 | +1,677,367 | 40.31% | $18,125,891,000 | 4 qtrs |
| SB INVESTMENT ADVISERS UK LTD | Reduced | 71,361,388 | -1,670,279 | 6.97% | $754,289,871 | 11 qtrs |
| VIKING GLOBAL INVESTORS LP | Reduced | 69,155,846 | -213,115 | 2.81% | $730,977,292 | 11 qtrs |
| QVT Financial LP | Unchanged | 66,719,779 | 0 | 66.32% | $705,228,064 | 11 qtrs |
| FMR LLC | Added | 46,551,146 | +11,210,583 | 0.03% | $492,045,614 | 11 qtrs |
| BlackRock Inc | Reduced | 35,370,270 | -817,249 | < 0.01% | $373,863,754 | 11 qtrs |
| MORGAN STANLEY | Reduced | 29,330,139 | -6,305,362 | 0.02% | $310,019,597 | 11 qtrs |
| Rubric Capital Management LP | Added | 23,000,000 | +3,000,000 | 6.37% | $243,110,000 | 7 qtrs |
| STATE STREET CORPORATION | Added | 18,442,688 | +1,289,554 | < 0.01% | $194,939,212 | 11 qtrs |
| Patient Square Capital LP | Unchanged | 12,228,465 | 0 | 59.99% | $129,254,875 | 7 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 13, 2024
- Filing type
- 13F-HR
- Position type
- SHS
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.